Immediate Therapeutic Effects of Diquafosol and Rebamipide in Dry Eye Disease

NCT07297316 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye Disease (DED)

Interventions

DRUG: 3% diquafosol (right eye) and 2% rebamipide (left eye)
DRUG: 2% rebamipide (right eye) and 3% diquafosol (left eye)

Sponsor

Korea University Anam Hospital

Collaborators

[object Object]